| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
21,586 |
12,183 |
$20.87M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,210 |
2,470 |
$3.83M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,539 |
4,109 |
$433K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,107 |
6,836 |
$284K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
13,200 |
6,285 |
$158K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,435 |
6,107 |
$69K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,295 |
1,140 |
$27K |
| 86328 |
|
781 |
745 |
$26K |
| 0001A |
|
332 |
309 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,475 |
1,292 |
$6K |
| 80053 |
Comprehensive metabolic panel |
1,008 |
894 |
$6K |
| 0002A |
|
141 |
131 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
495 |
456 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
179 |
169 |
$3K |
| J7050 |
Infusion, normal saline solution, 250 cc |
149 |
128 |
$3K |
| 87807 |
|
261 |
255 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
103 |
102 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
113 |
105 |
$2K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
26 |
25 |
$2K |
| 81003 |
|
1,053 |
949 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
276 |
272 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
60 |
57 |
$871.84 |
| 81025 |
|
165 |
147 |
$726.02 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
38 |
24 |
$696.06 |
| G9498 |
Antibiotic regimen prescribed |
16 |
14 |
$302.37 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
91 |
79 |
$261.68 |
| 84484 |
|
19 |
13 |
$70.02 |
| 82553 |
|
19 |
13 |
$64.89 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
39 |
25 |
$61.05 |
| 82550 |
|
19 |
13 |
$36.59 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
13 |
12 |
$1.84 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
20 |
15 |
$0.00 |